Sign in

CIK 0001034842 · Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943248524
Phone
650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-11-25 Schorno Dean L EVP & Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +6,250 6,250
2024-08-30 RODRIGUEZ RAUL R CEO, President Grant or award · Employee Stock Option (right to buy) +32,500 32,500
2024-08-30 Schorno Dean L EVP & Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +10,000 10,000
2024-05-25 Wasman Jane Director Grant or award +25,000 100,000
2024-05-25 Wasman Jane Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-05-25 MOOS WALTER H Director Grant or award +25,000 102,222
2024-05-25 MOOS WALTER H Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-05-25 LAPOINTE ANTHONY GREGG Director Grant or award +25,000 100,000
2024-05-25 LAPOINTE ANTHONY GREGG Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-05-25 Kotzin Brian L. Director Grant or award +25,000 100,000
2024-05-25 Kotzin Brian L. Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-05-25 HANNAH ALISON L. Director Grant or award +25,000 81,250
2024-05-25 HANNAH ALISON L. Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-05-25 Ali-Jackson Kamil Director Grant or award +25,000 68,750
2024-05-25 Ali-Jackson Kamil Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-03-27 Rojkjaer Lisa EVP, Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +187,500 187,500
2024-02-28 Schorno Dean L EVP & Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +62,500 62,500
2024-02-28 Schorno Dean L EVP & Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +78,500 78,500
2024-02-28 Santos David A EVP, Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +80,000 80,000
2024-02-28 Santos David A EVP, Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +78,500 78,500

Page 7 of 9 · 176 trades